Modified Atkins Diet for Cognitive Loss in Older Adults

About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
July 01, 2016 - June 30, 2019
Grant ID
A2016073S
Acknowledgement
Goals
This study will test whether a special diet that has been used to treat other brain disorders may be useful to treat Alzheimer’s disease (AD). The diet is very low in starches and sugars, and very high in fat. Such a diet causes the body to produce substances called “ketones” which can be used by the brain for energy. This study will test whether patients with early AD or even milder memory problems [known as mild cognitive impairment (MCI)] can stick to this diet for 12 weeks and whether it improves their thinking and memory.
Summary
Lots of excellent research over many years has shown that the brains of people with Alzheimer’s disease (AD) are unable to use glucose normally. Glucose is a simple sugar that is produced by the metabolism of carbohydrates. We are studying whether ketone bodies, which are produced when dietary fats are metabolized, can be used as an alternative energy source. Patients with mild cognitive impairment (MCI) or early AD are being randomly assigned to a very high-fat, very low-carbohydrate diet (the modified Atkins diet) or a low-fat diet high in fruits, vegetables and grains for 12 weeks. Education and support is provided by expert nutritionists and dieticians. Ability to adhere to the diet is being measured, as are the effects of the diets on memory and other cognitive functions. We are also studying changes in blood indicators of inflammation and fat metabolism. If the modified Atkins diet proves to be acceptable to patients and improves cognitive functioning (or slows its decline), it might become a standard treatment for AD.
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD